YIH
ROIV icon

Y-Intercept (HK)’s Roivant Sciences ROIV Stock Holding History

Y-Intercept (HK)’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.9M Buy
+110,340
New +$3.26M 0.08% 365
2026
Q1 		– Sell
-67,342
Closed -$1.46M – 1979
2025
Q4 		$1.46M Sell
67,342
-805,739
-92% -$15.9M 0.03% 785
2025
Q3 		$13.2M Buy
873,081
+601,178
+221% +$7.44M 0.32% 45
2025
Q2 		$3.06M Buy
+271,903
New +$2.95M 0.07% 412
2024
Q1 		– Sell
-91,593
Closed -$1.03M – 1700
2023
Q4 		$1.03M Buy
91,593
+52,029
+132% +$507K 0.1% 310
2023
Q3 		$462K Buy
+39,564
New +$447K 0.05% 589

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Y-Intercept (HK)'s ROIV Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Roivant Sciences (ROIV) in Q2 2026: 110,340 shares worth $3.9M. The stake represents 0.08% of the portfolio and ranks #365 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in ROIV as recently as Q4 2025.

Y-Intercept (HK) first reported a position in ROIV in Q3 2023 and has held it in 6 quarters since. The position peaked at $13.2M in Q3 2025. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Y-Intercept (HK) held 110,340 shares of Roivant Sciences worth $3.9M as of Q2 2026.
  • Roivant Sciences was a new Y-Intercept (HK) position in Q2 2026.
  • Roivant Sciences made up 0.08% of Y-Intercept (HK)'s portfolio in Q2 2026, its #365 holding.
  • Y-Intercept (HK) first reported a position in Roivant Sciences in Q3 2023 and has held it in 6 quarters since.
  • Y-Intercept (HK)'s Roivant Sciences position peaked at $13.2M in Q3 2025.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.